Granulomatosis with polyangiitis following Pfizer-BioNTech COVID-19 vaccination

11Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

We report the first case of proteinase 3-antineutrophil cytoplasmic antibody-positive granulomatosis with polyangiitis (GPA) with predominant ears, nose, and throat manifestations following coronavirus disease 2019 (COVID-19) vaccination. A 63-year-old woman presented with aural fullness 3 days after vaccination. She presented with progressive rhinosinusitis and otitis media leading to profound hearing loss within 3 weeks. Clinical imaging revealed soft-tissue shadows in the paranasal sinuses with multiple pulmonary nodules, and histopathology was consistent with a diagnosis of GPA. It is crucial to be wary of the possibility of GPA in patients who received COVID-19 vaccines due to its rapid disease progression.

Cite

CITATION STYLE

APA

Shirai, T., Suzuki, J., Kuniyoshi, S., Tanno, Y., & Fujii, H. (2023). Granulomatosis with polyangiitis following Pfizer-BioNTech COVID-19 vaccination. Modern Rheumatology Case Reports, 7(1), 127–129. https://doi.org/10.1093/mrcr/rxac016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free